Form 8-K - Current report:
SEC Accession No. 0001104659-25-045309
Filing Date
2025-05-07
Accepted
2025-05-07 07:10:40
Documents
48
Period of Report
2025-05-07
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2514050d1_8k.htm   iXBRL 8-K 39619
2 EXHIBIT 99.1 tm2514050d1_ex99-1.htm EX-99.1 22409
3 EXHIBIT 99.2 tm2514050d1_ex99-2.htm EX-99.2 44961
7 GRAPHIC tm2514050d1_ex99-1img001.jpg GRAPHIC 17194
8 GRAPHIC tm2514050d1_ex99-2img001.jpg GRAPHIC 147525
9 GRAPHIC tm2514050d1_ex99-2img002.jpg GRAPHIC 286082
10 GRAPHIC tm2514050d1_ex99-2img003.jpg GRAPHIC 156229
11 GRAPHIC tm2514050d1_ex99-2img004.jpg GRAPHIC 86519
12 GRAPHIC tm2514050d1_ex99-2img005.jpg GRAPHIC 127425
13 GRAPHIC tm2514050d1_ex99-2img006.jpg GRAPHIC 165446
14 GRAPHIC tm2514050d1_ex99-2img007.jpg GRAPHIC 147769
15 GRAPHIC tm2514050d1_ex99-2img008.jpg GRAPHIC 171912
16 GRAPHIC tm2514050d1_ex99-2img009.jpg GRAPHIC 168703
17 GRAPHIC tm2514050d1_ex99-2img010.jpg GRAPHIC 159539
18 GRAPHIC tm2514050d1_ex99-2img011.jpg GRAPHIC 145702
19 GRAPHIC tm2514050d1_ex99-2img012.jpg GRAPHIC 179683
20 GRAPHIC tm2514050d1_ex99-2img013.jpg GRAPHIC 145153
21 GRAPHIC tm2514050d1_ex99-2img014.jpg GRAPHIC 175201
22 GRAPHIC tm2514050d1_ex99-2img015.jpg GRAPHIC 174859
23 GRAPHIC tm2514050d1_ex99-2img016.jpg GRAPHIC 203550
24 GRAPHIC tm2514050d1_ex99-2img017.jpg GRAPHIC 107099
25 GRAPHIC tm2514050d1_ex99-2img018.jpg GRAPHIC 181321
26 GRAPHIC tm2514050d1_ex99-2img019.jpg GRAPHIC 175267
27 GRAPHIC tm2514050d1_ex99-2img020.jpg GRAPHIC 175157
28 GRAPHIC tm2514050d1_ex99-2img021.jpg GRAPHIC 137594
29 GRAPHIC tm2514050d1_ex99-2img022.jpg GRAPHIC 133345
30 GRAPHIC tm2514050d1_ex99-2img023.jpg GRAPHIC 123981
31 GRAPHIC tm2514050d1_ex99-2img024.jpg GRAPHIC 152685
32 GRAPHIC tm2514050d1_ex99-2img025.jpg GRAPHIC 170646
33 GRAPHIC tm2514050d1_ex99-2img026.jpg GRAPHIC 139730
34 GRAPHIC tm2514050d1_ex99-2img027.jpg GRAPHIC 135564
35 GRAPHIC tm2514050d1_ex99-2img028.jpg GRAPHIC 208132
36 GRAPHIC tm2514050d1_ex99-2img029.jpg GRAPHIC 111581
37 GRAPHIC tm2514050d1_ex99-2img030.jpg GRAPHIC 133781
38 GRAPHIC tm2514050d1_ex99-2img031.jpg GRAPHIC 314201
39 GRAPHIC tm2514050d1_ex99-2img032.jpg GRAPHIC 298949
  Complete submission text file 0001104659-25-045309.txt   7692404

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA syn-20250507.xsd EX-101.SCH 3041
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syn-20250507_pre.xml EX-101.PRE 22377
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE syn-20250507_lab.xml EX-101.LAB 34239
50 EXTRACTED XBRL INSTANCE DOCUMENT tm2514050d1_8k_htm.xml XML 3692
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Theriva Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12584 | Film No.: 25919259
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)